| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.004 |